It has been revealed that the COVID vaccines are refusing to leave the spotlight. Check out the latest reports about a new connection that has been made between these and human health.
New COVID-19 vaccine correlations
As COVID-19 vaccination rates continue to rise, more and more people are reporting side effects. Studies have found that viral vector-based vaccines for COVID-19 can increase the risk of Guillain-Barré syndrome (GBS) by three to four times compared to mRNA-based vaccines.
It is also worth noting the fact that there is increasing evidence suggesting a link between COVID-19 vaccines and Guillain-Barré Syndrome.
One study found a rise in GBS cases within 42 days of receiving the first dose of the AstraZeneca vaccine. Based on their findings, the researchers suggest a possible link between the AstraZeneca vaccine and the increased risk of GBS.
A surveillance study published in Scientific Reports in March 2022 looked at 38,828,691 COVID-19 vaccine doses administered in Gyeonggi Province, South Korea between February 2021 and March 2022.
The study reported that out of the total doses administered, 105,409 adverse events were reported, including 55 cases of Guillain-Barré Syndrome (GBS).
Further analysis of the data showed that viral vector-based vaccines carried a three-to-fourfold higher risk of GBS compared to mRNA-based vaccines.
Additionally, GBS occurred more frequently in men than women and was more common in individuals aged 60 and older than in younger age groups.
Recent research shows that viral vector-based COVID-19 vaccines have a higher incidence rate of neurological complications, such as Guillain-Barré Syndrome (GBS), compared to mRNA-based vaccines like Pfizer and Moderna. Healthcare providers are advised to closely monitor individuals who have received COVID-19 vaccinations, particularly men who have received their first dose of viral vector-based vaccines.
GBS affects multiple peripheral nerves in the body, leading to polyneuropathy which can also affect the nerves controlling the functions of the heart and circulation system.
